Insider sales reported at Arcutis Biotherapeutics (NASDAQ: ARQT) — two 10,000-share disposals

Rhea-AI Filing Summary

Arcutis Biotherapeutics (ARQT) reported proposed sales of Common Stock under a Form 144 by Howard Welgus. The filing lists two recent dispositions: 10,000 shares sold on 03/02/2026 for $256,517.50 and 10,000 shares sold on 02/02/2026 for $250,482.69. The notice also references 10,000 shares tied to a prior stock option exercise on 06/04/2018.

Insights

Securities Compliance Analyst

Form 144 discloses proposed insider sales and past dispositions by the named holder.

The filing lists proposed and completed sales by Howard Welgus, including two recorded dispositions of 10,000 shares each on 03/02/2026 and 02/02/2026

These entries reflect routine insider liquidity reporting requirements; cash proceeds are shown next to each past sale. Additional context about remaining holdings or any trading plan is not provided in the excerpt.

Key Figures

Sale on 03/02/2026: 10,000 shares Sale on 02/02/2026: 10,000 shares Securities to be sold / tied to exercise: 10,000 shares +1 more

4 metrics

Sale on 03/02/2026 10,000 shares disposition recorded for $256,517.50

Sale on 02/02/2026 10,000 shares disposition recorded for $250,482.69

Securities to be sold / tied to exercise 10,000 shares stock option exercise dated 06/04/2018

Form type Form 144 notice of proposed sale of securities

Key Terms

Form 144, stock option exercise, Common

3 terms

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

stock option exercise financial

"Common | 06/04/2018 | Stock option exercise"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Common market

"Securities To Be Sold | Common | 10000"

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill 8890 Lyra Dr 5th Floor Columbus OH 43215	10000	238800.86	122492192	04/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/04/2018	Stock option exercise	Arcutis Biotherapeutics Inc			10000	06/04/2018	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Howard Welgus 3027 Townsgate Rd Ste 300 Westlake Village CA 91361	Common	03/02/2026	10000	256517.5
Howard Welgus 3027 Townsgate Rd Ste 300 Westlake Village CA 91361	Common	02/02/2026	10000	250482.69

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Arcutis Biotherapeutics' (ARQT) Form 144 show?

The Form 144 shows proposed and recent insider sales by Howard Welgus. It lists 10,000 shares sold on 03/02/2026 for $256,517.50 and 10,000 shares sold on 02/02/2026 for $250,482.69.

Who is the reporting person on the ARQT Form 144?

The filing identifies Howard Welgus with an address in Westlake Village, CA. The filing records his recent dispositions and the proposed sale of Common Stock as shown in the notice.

How many shares are listed as proposed to be sold in the Form 144?

The notice references 10,000 shares as securities to be sold and shows past sales of 10,000 shares on two dates. The filing text ties a 10,000-share figure to a prior option exercise.

Are proceeds from the sales disclosed in the ARQT excerpt?

Yes. The excerpt lists proceeds next to each past sale: $256,517.50 for the 03/02/2026 sale and $250,482.69 for the 02/02/2026 sale as recorded in the Form 144.

Does the Form 144 show how the shares were acquired?

The filing notes a stock option exercise dated 06/04/2018 associated with the 10,000-share quantity, indicating the shares were acquired via exercise of options on that date.